Search

Search Results
Results 8641 - 8650 of 8673 for Dementia
  • News - 3 May 2004
    Substance use disorders don’t discriminate. In fact, anyone can have a problem with prescription medication, alcohol, or illicit drugs—including adults aged 55 and older.
  • News - 13 Apr 2004
    A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased...
  • White Paper - 19 May 2022
    In this article, ACROBiosystems discusses how the complement cascade and it's various components could potentially be leveraged for therapeutic potential in COVID-19, cancer and general inflammation.
  • News - 18 Mar 2013
    The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013,...
  • Drug - 19 Sep 2024
    Consumer Medicine Information (CMI) about Scemblix intended for persons living in Australia.
  • Drug - 6 Sep 2024
    Consumer Medicine Information (CMI) about Bijuva 1/100 intended for persons living in Australia.
  • Drug - 8 Jul 2024
    Consumer Medicine Information (CMI) about Syquet (Quetiapine fumarate) intended for persons living in Australia.
  • Drug - 21 May 2024
    Consumer Medicine Information (CMI) about Premarin (Conjugated estrogens Tablets) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Vagifem Low (Estradiol) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Estrofem (Estradiol) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.